Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Impact of Perelel Prenatal on Biomarkers in Healthy Pregnant Women.

NCT07226414 is registered in ClinicalTrials.gov with Perelel Inc. as lead sponsor.

NCT NCT07226414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07226414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Impact of Perelel Prenatal on Biomarkers in Healthy Pregnant Women.
Lead sponsor
Perelel Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
December 1, 2025
Completion date
November 30, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy